{
    "doi": "https://doi.org/10.1182/blood-2019-121843",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=4440",
    "start_url_page_num": 4440,
    "is_scraped": "1",
    "article_title": "Prediction of Cardiac Complications in SCD ",
    "article_date": "November 13, 2019",
    "session_type": "114.Hemoglobinopathies, Excluding Thalassemia-Clinical",
    "topics": [
        "cardiac complications",
        "cardiac mri",
        "iron overload",
        "ventricular mass",
        "acute chest syndrome",
        "cardiac event",
        "cardiovascular event",
        "follow-up",
        "gold standard",
        "heart failure"
    ],
    "author_names": [
        "Alessia Pepe, MD",
        "Laura Pistoia",
        "Maria Rita Gamberini, MD",
        "Silvia Macchi, MD",
        "Francesca Valeria Commendatore",
        "Elena Facchini, MD",
        "Lorella Pitrolo",
        "Mauro Celli",
        "Aurelio Maggio, MD",
        "Paolo Preziosi",
        "Vincenzo Positano",
        "Antonella Meloni, PhD"
    ],
    "author_affiliations": [
        [
            "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
        ],
        [
            "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
        ],
        [
            "Unit\u00e0 Operativa di Day Hospital della Talassemia e delle Emoglobinopatie, Azienda Ospedaliero-Universitaria \"S. Anna\", Ferrara, Italy "
        ],
        [
            "Servizio Trasfusionale, Ospedale Santa Maria delle Croci, Ravenna, Italy "
        ],
        [
            "Unit\u00e0 Operativa Semplice di Talassemia, Presidio Ospedaliero Lentini - ASP 8 Siracusa, Lentini (SR), Italy "
        ],
        [
            "U.O. di Pediatria -Prof A. Pession, Azienda Ospedaliero-Universitaria di Bologna - Policlinico \"S. Orsola-Malpighi\", Bologna, Italy "
        ],
        [
            "Ematologia II con Talassemia, Ospedale \"V. Cervello\", Palermo, Italy "
        ],
        [
            "Unit\u00e0 Operativa Complessa di ImmunoEmatologia, Policlinico Umberto 1, Roma, Italy "
        ],
        [
            "Ematologia II con Talassemia, Ospedale \"V. Cervello\", Palermo, Italy ",
            "Campus of Hematology Franco and Piera Cutino, AOOR Villa Sofia, Ospedale \"V. Cervello\", Palermo, Italy "
        ],
        [
            "Unit\u00e0 Operativa Complessa Diagnostica per Immagini, Ospedale \"Sandro Pertini\", Roma, Italy"
        ],
        [
            "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
        ],
        [
            "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
        ]
    ],
    "first_author_latitude": "43.71766555",
    "first_author_longitude": "10.408049799999999",
    "abstract_text": "Introduction: Cardiac magnetic resonance (CMR) is the non-invasive gold standard for the quantification of biventricular functional parameters and for myocardial tissue characterization. The aim of this study was to prospectively assess the predictive value of CMR parameters for cardiovascular complications in sickle cell disease (SCD) patients. Methods: We considered 102 white SCD patients (34.38\u00b112.67 years, 53 females) consecutively enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) network. Myocardial iron overload (MIO) was measured by the multislice multiecho T2* technique. Atrial dimensions and biventricular function parameters were quantified by cine images. Results: At baseline CMR only two patients had MIO (global heart T2*<20 ms). During a mean follow-up was of 63.29\u00b124.41 months, 10 cardiac events (9.8%) were registered: 3 pulmonary hypertension, 1 pulmonary embolism, 1 peripheral vascular disease, 1 transient ischemic attack, 2 supraventricular arrhythmias, 1 heart failure, and 1 death after acute chest syndrome. CMR predictors of cardiovascular events at univariate analysis were left ventricular ejection fraction and right ventricular mass index (see Table). Both variables remained independent predictors at multivariate analysis (see Table). Conclusions : Reduced left ventricular ejection fraction and increased right ventricular mass index showed a significant prognostic value in patients with SCD. Our data seem to suggest that also CMR could be added as screening tool for identifying SCD patients at high risk for pulmonary and systemic vasculopathy and death. Table View large Download slide Table View large Download slide  Disclosures Pepe: Chiesi Farmaceutici S.p.A., ApoPharma Inc., and Bayer: Other: No profit support."
}